Deutsche Bank’s Edwards Lifesciences EW Stock Holding History

Deutsche Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-324	Closed	-$19K	–	5215
2018 Q3	$19K	Buy	+324	New	+$15.8K	﹤0.01%	4942
2018 Q1	–	Sell	-750	Closed	-$28K	–	5460
2017 Q4	$28K	Buy	+750	New	+$27.5K	﹤0.01%	4591
2015 Q1	–	Sell	-7,044	Closed	-$149K	–	5334
2014 Q4	$149K	Hold	7,044	–	–	﹤0.01%	4458
2014 Q3	$119K	Hold	7,044	–	–	﹤0.01%	4397
2014 Q2	$100K	Sell	7,044 -2,652	-27%	-$36K	﹤0.01%	4568
2014 Q1	$21K	Hold	9,696	–	–	﹤0.01%	4822
2013 Q4	$12K	Buy	+9,696	New	+$109K	﹤0.01%	4850

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Deutsche Bank's EW Position: Q2 2026 in Review

Deutsche Bank reduced its Edwards Lifesciences (EW) stake by 5.7% in Q2 2026, selling an estimated $28.9M and leaving 5,710,284 shares worth $517M. The position accounts for 0.15% of the portfolio, ranked #132.

Deutsche Bank first reported a position in EW in Q2 2013 and has held it in 53 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Deutsche Bank held 5,710,284 shares of Edwards Lifesciences worth $517M as of Q2 2026.
Deutsche Bank sold 344,739 Edwards Lifesciences shares in Q2 2026, an estimated $28.9M.
Edwards Lifesciences made up 0.15% of Deutsche Bank's portfolio in Q2 2026, its #132 holding.
Deutsche Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.